Small molecules modulator of epigenetic regulation and their therapeutic applications
US9750731B2 · kind B2 · utility
0Cited by
1References
1Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 21, 2014 |
| Grant date | Sep 5, 2017 |
| Priority date | — |
| Expiry date | Nov 11, 2034 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2500/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Disclosed are methods and compositions for modulating the function of transcription factors, especially transcription factors that recruit epigenetic regulators (histone modifying enzymes) to specific DNA promoters. The targeted transcription factors include but are not limited to the myocyte enhancing factor (MEF2), the forkhead/winged helix transcription factor FOXP3 and the transcription factor GATA3. Also disclosed are small molecule modulators of MEF2 and its associated factors that include but not limited to histone deacetylases (HDACs), p300/CBP and Cabin1 and the therapeutic applications thereof.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.